Sphingolipid metabolites as potential circulating biomarkers for sarcopenia in men.

Je Hyun Seo, Jung-Min Koh, Han Jin Cho, Hanjun Kim, Young-Sun Lee, Su Jung Kim, Pil Whan Yoon, Won Kim, Sung Jin Bae, Hong-Kyu Kim, Hyun Ju Yoo, Seung Hun Lee

Veterans Health Service Medical Center, Veterans Medical Research Institute, Seoul, South Korea.Veterans Health Service Medical Center, Veterans Medical Research Institute, Seoul, South Korea. · pubmed

Paper

Abstract

Sarcopenia is an age-related progressive loss of muscle mass and function. Sarcopenia is a multifactorial disorder, including metabolic disturbance; therefore, metabolites may be used as circulating biomarkers for sarcopenia. We aimed to investigate potential biomarkers of sarcopenia using metabolomics.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper investigates potential biomarkers for sarcopenia, which is an age-related condition associated with the loss of muscle mass and function. While it addresses a significant aspect of aging, the focus on biomarkers does not directly tackle the root causes of aging or aim for lifespan extension. The findings may contribute to understanding sarcopenia better, but they represent a solid yet limited advance in the field rather than a transformative breakthrough.

Author of this paper? Send a correction.